SCHEMBL7373349

SCHEMBL7373349

COC(=O)c1ccccc1NS(=O)(=O)c1cccc(C(=O)O)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.68
MEN1 O00255 6/20 0.68
GAA P10253 2/20 0.68
TSHR P16473 2/20 0.64
KDM4E B2RXH2 2/20 0.64
PTK2B Q14289 1/20 0.64
RAB9A P51151 1/20 0.61
ACLY P53396 3/20 0.61
LMNA P02545 2/20 0.57
ALDH1A1 P00352 2/20 0.57
CYP3A4 P08684 1/20 0.57
CYP2D6 P10635 1/20 0.57
CYP2C9 P11712 1/20 0.57
HPGD P15428 1/20 0.57
CRHBP P24387 1/20 0.57
CYP2C19 P33261 1/20 0.57
HTT P42858 1/20 0.57
CRHR2 Q13324 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
NOD2 Q9HC29 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7370095 0.88 TSHR (0.77) KMT2AMEN1GAATSHRKDM4E
SCHEMBL13011714 0.86 KMT2A (0.74) KMT2AMEN1GAATSHRKDM4E
SCHEMBL3283149 0.85 KMT2A (0.69) KMT2AMEN1GAATSHRKDM4E
SCHEMBL7457320 0.85 CASP3 (0.64) KMT2AMEN1GAATSHRKDM4E
SCHEMBL23200347 0.83 KEAP1 (0.65) KMT2AMEN1GAATSHRKDM4E
SCHEMBL14659917 0.81 KMT2A (0.52) KMT2AMEN1GAATSHRKDM4E
SCHEMBL1981780 0.80 METAP2 (0.68) KMT2AMEN1GAATSHRKDM4E
SCHEMBL7569668 0.80 KMT2A (0.76) KMT2AMEN1GAATSHRKDM4E
SCHEMBL5467189 0.79 DDX3X (0.66) KMT2AMEN1GAAKDM4ELMNA
SCHEMBL9997041 0.79 AKR1C3 (0.59) KMT2AMEN1GAATSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001074786-A1 HETEROBIARYLSULPHONAMIDES AND THEIR USE AS PDE 7 INHIBITORS DARWIN DISCOVERY LIMITED (GB) 2001-10-11 WO disclosed